Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
Authors
Keywords
-
Journal
Molecular Oncology
Volume 10, Issue 1, Pages 113-125
Publisher
Wiley
Online
2015-09-09
DOI
10.1016/j.molonc.2015.06.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue
- (2014) Kazuya Ishikawa et al. AURIS NASUS LARYNX
- Serum soluble ST2 is associated with ER-positive breast cancer
- (2014) Da-peng Lu et al. BMC CANCER
- IL-33 attenuates the development of experimental autoimmune uveitis
- (2014) Mark Barbour et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+T and NK Cells
- (2014) Xin Gao et al. JOURNAL OF IMMUNOLOGY
- High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma
- (2014) Dominik Bergis et al. Translational Oncology
- Significance of Interleukin-33 and Its Related Cytokines in Patients with Breast Cancers
- (2014) Jing Liu et al. Frontiers in Immunology
- Serum IL-33 as a Diagnostic and Prognostic Marker in Non-small Cell Lung Cancer
- (2013) Liang-An Hu et al. Asian Pacific Journal of Cancer Prevention
- Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
- (2013) Kun Gao et al. CANCER LETTERS
- Emerging role of interleukin-33 in autoimmune diseases
- (2013) Cheng Pei et al. IMMUNOLOGY
- Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
- (2013) Ivan P. Jovanovic et al. INTERNATIONAL JOURNAL OF CANCER
- Enhancement of the p38 MAPK and PKA signaling pathways is associated with the pro-melanogenic activity of Interleukin 33 in primary melanocytes
- (2013) Jia Zhou et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma
- (2013) Su-Feng Chen et al. JOURNAL OF PATHOLOGY
- Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer
- (2013) Vincent Lavoué et al. Journal of Translational Medicine
- IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling
- (2013) Wen-Ting Hu et al. MOLECULAR HUMAN REPRODUCTION
- Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells
- (2013) Kuan-Min Fang et al. NEURO-ONCOLOGY
- IL-33: a Janus cytokine: Table 1
- (2012) F Y Liew ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells
- (2012) Annett Schmieder et al. CYTOKINE
- IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages
- (2012) Hui-Rong Jiang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-33/ST2 axis in inflammation and immunopathology
- (2012) Marija Milovanovic et al. IMMUNOLOGIC RESEARCH
- Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue
- (2012) M Zeyda et al. INTERNATIONAL JOURNAL OF OBESITY
- Serum Interleukin-33 Levels in Patients with Gastric Cancer
- (2011) Pinghu Sun et al. DIGESTIVE DISEASES AND SCIENCES
- IL-33-activated dendritic cells are critical for allergic airway inflammation
- (2011) Anne-Gaëlle Besnard et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
- (2011) Ivan Jovanovic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production
- (2009) Y.-S. Choi et al. BLOOD
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation
- (2009) M. Kurowska-Stolarska et al. JOURNAL OF IMMUNOLOGY
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
- (2009) G. Solinas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- IL-33 reduces the development of atherosclerosis
- (2008) Ashley M. Miller et al. JOURNAL OF EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search